Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:BlackRock and AQR Bet Against This Fund Firm Not Rated 0.0 Email Routing List Email & Route  Print Print
Tuesday, March 1, 2016

BlackRock and AQR Bet Against This Fund Firm

News summary by MFWire's editors

It's Larry Fink versus Martin Gilbert. Actually, it's the PMs at Fink's Blackrock [profile] versus the share price of Gilbert's Aberdeen [profile]. And word is that AQR is already betting against Aberdeen, too.

Larry Fink
BlackRock
Chief Executive Officer
Madison Marriage and David Oakley of the Financial Times report that in mid-February New York-based BlackRock took a 0.58-percent short position against Scotland-based Aberdeen. The move comes as the LSE is expected to pull Aberdeen out of the FTSE 100 index tomorrow and down into the FTSE 250.

2015 and 2016 have been rough for Aberdeen, which has suffered from the stock market pain in emerging markets. It's shares are down nearly 17 percent year-to-date as of market close yesterday, and they're down more than 48 percent in the past 12 months. Gilbert, Aberdeen's founder and CEO, has been fighting off rumors of a possible Aberdeen sale.
Martin Gilbert
Aberdeen Asset Management
Chief Executive Officer
 

Edited by: Neil Anderson, Managing Editor


Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use